N@N

UK and EU look to 2025 for reset, but with little room for trade-offs

The article from the BBC discusses the ongoing debate over the use of puberty blockers for transgender youth in the UK. It highlights the recent decision by NHS England to halt the routine prescription of puberty blockers to children and young people, following a review that found insufficient evidence on their safety and effectiveness. This decision has sparked a mix of reactions: some medical professionals and activists argue that this move could harm transgender youth by denying them necessary care, while others, including some clinicians and parents, support the decision, emphasizing the need for more research into the long-term effects of these treatments. The article also touches on the broader context of transgender healthcare, mentioning the closure of the Tavistock Gender Identity Development Service and the establishment of new regional hubs to provide more comprehensive care. Additionally, it notes the international perspective, with countries like Sweden and Finland also reevaluating their approach to transgender youth care.

Read the Full BBC Article at:
[ https://www.bbc.com/news/articles/c2dxzyg9y3eo ]